StockCIK 1745999

Beam Therapeutics Inc. (BEAM): Insider Trades and Fund Holdings

In the past 12 months, Beam Therapeutics Inc. insiders reported 0 open-market purchases worth $0 and 3 sales worth $1.19M; 3 of the sales were reported as made under a 10b5-1 trading plan.

0Insider buys, 12 months

$0Bought by insiders, 12 months

$1.19MSold by insiders, 12 months

2Tracked funds holding

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Oct 16, 2026.

Recent BEAM insider trades
Filed	Traded	Insider	Role	Type	Shares	Price ($)	Value	Holding	Filing
Oct 16	Oct 16	John M. EvansCEO	CEO	▼ SELL10b5-1	25,000	23.98	$600K	−2.3%	Form 4 ↗
Oct 16	Oct 15	John M. EvansCEO	CEO	▼ SELL10b5-1	25,000	23.57	$589K	−2.3%	Form 4 ↗
Oct 2	Oct 1	Bethany J. CavanaghSVP	SVP	▼ SELL10b5-1	187	24.41	$5K	−0.4%	Form 4 ↗

Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings

Insiders who traded in the past year

Insider	Role	Buys	Bought	Sells	Sold	Latest
John M. Evans	CEO	0	$0	2	$1.19M	Oct 16, 2026
Bethany J. Cavanagh	SVP	0	$0	1	$5K	Oct 2, 2026

Tracked funds that report BEAM

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

Fund	Quarter	Shares	Value	% of portfolio	Change
Renaissance Technologies	Q2 2026	445,000	$15.3M	0.02%	▼ −13.4%
Duquesne Family Office	Q2 2026	153,600	$5K	0.12%	▲ New

Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →